Startup profile for Basata: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.
Venture Capital Tracker logo
Venture Capital Tracker

Startup profile · funding coverage

Basata funding, valuation and investors

Specialty-specific AI agents automating healthcare admin — referrals, intake, scheduling, and follow-up.

Keep track of Basata

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series A

$21M · May 2026

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$21M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series a · Phoenix, Arizona

Investors in latest funding

Lead: Basis Set Ventures

Other: Cowboy Ventures , PHX Ventures , Zenda Capital

Sources: latest funding · prnewswire.com Last verified: 2026-07-25

Overview

Basata deploys specialty-specific AI agents that automate healthcare administrative workflows end-to-end — from faxed referrals to patient intake, AI voice scheduling, and EHR chart creation. Founded by CEO Kaled Alhanafi, the Phoenix company raised a $21M Series A in May 2026 led by Basis Set Ventures with participation from Cowboy Ventures, PHX Ventures, Zenda Capital, and Victoria Treyger, bringing total funding to $24.5M. Practices using Basata report processing 100% of incoming referrals the same day and unlocking roughly 50% more administrative capacity.

Why Basata is interesting

Basata processes faxes into booked appointments in minutes — 500K+ patients served with same-day referral processing for cardiology, urology, and other specialty groups.

Product & use cases

Basata's AI agents handle healthcare admin end-to-end — reading faxed referrals, creating EHR charts, calling patients via AI voice agents, and booking appointments in minutes instead of weeks.

  • Autonomous referral processing from fax to scheduled appointment
  • AI voice agents for patient intake and scheduling
  • Specialty-specific workflows for cardiology, urology, gastroenterology, ophthalmology

Key facts

  • Series A (May 2026): $21M led by Basis Set Ventures; Cowboy Ventures participated — $24.5M total raised (PR Newswire)
  • 500K+ patients served; 100K in the past month alone (PR Newswire)
  • Practices report 100% same-day referral processing and ~50% admin capacity gain (HIT Consultant)
  • Specialties: cardiology, urology, gastroenterology, ophthalmology (company press)

Funding history (newest first)

Series A

2026-05 $21M

Source: Read source · prnewswire.com

Investors in our directory

Funds linked from Basata's profile — open a fund page for stage focus and related deal articles.

cowboy-ventures

Competitive landscape

Edge: Specialty-tuned agents built alongside administrators in the trenches — replaces patchwork point solutions with one agentic operating system for practice operations.

Healthcare admin still runs on fax machines and phone trees despite AI progress elsewhere. Basata's specialty-specific agents target the $1T operational layer — competing with point solutions and manual workflows rather than a single dominant platform. Success depends on specialty workflow depth and EHR integration quality; Cowboy Ventures' Series A participation signals seed-stage validation of early traction metrics.

  • Notable Health adjacent

    Healthcare automation; Basata focuses on specialty practice admin and fax-to-appointment loop.

  • Olive AI (wind-down) adjacent

    Prior revenue-cycle automation entrant; Basata targets front-office ops not RCM.

  • Manual call centers + fax incumbent

    Default for most specialty practices; Basata replaces hold music and manual data entry.

  • Epic scheduling modules incumbent

    EHR-native scheduling; Basata adds AI layer on top of existing EHR workflows.

Notable stories

  • CEO Kaled Alhanafi said patients still fight hold music and fax machines to get care in 2026 — Basata's mission is fully autonomous healthcare operations within a decade (PR Newswire).
  • The founding team spent weeks in the trenches with administrative staff to tailor AI to specialty-specific clinical workflows (HIT Consultant).
  • Basata's origin traces to the founder's mother's experience navigating healthcare access friction (HIT Consultant).

Industries

healthtech ai-ml enterprise-saas

Market / IPO context

Editorial / static context — not a live quote.

Related funding articles

Venture Capital Tracker pieces that cover Basata's financing or category context.

FAQs about Basata

Practical answers founders, operators, and investors typically search for.

Basata deploys AI agents that automate healthcare admin — reading faxed referrals, creating EHR charts, calling patients, and booking appointments end-to-end.
Basis Set Ventures led the $21M Series A; Cowboy Ventures (/fund/cowboy-ventures) participated alongside PHX Ventures and Zenda Capital.
May 8, 2026 — $21M Series A (PR Newswire).
500,000+ patients total, including 100,000 in the month before the Series A announcement (PR Newswire).
Basata focuses on specialty practice front-office automation (referrals, intake, scheduling); different workflow scope than RCM-focused tools.
Cardiology, urology, gastroenterology, ophthalmology, and expanding (company press).
Series A with $24.5M total funding as of May 2026.
Phoenix, Arizona.
Not publicly disclosed.
No — private as of July 2026.
Website All startups Funding news

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.